STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Codexis to Participate in TD Cowen 45th Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
conferences

Codexis (NASDAQ: CDXS), a leading enzymatic solutions provider for therapeutics manufacturing, has announced its participation in the TD Cowen 45th Annual Health Care Conference. The conference will take place from March 3-5, 2025, in Boston, Massachusetts.

The company's management will engage in a fireside chat on Tuesday, March 4, 2025, at 1:10 pm ET. Investors and interested parties can access a live webcast of the presentation through the Investor Relations section of Codexis's website at https://ir.codexis.com. The presentation recording will remain available for replay on the website for 90 days after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

REDWOOD CITY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the TD Cowen 45th Annual Health Care Conference, being held March 3-5, 2025, in Boston, Massachusetts.

Management will participate in a fireside chat on Tuesday, March 4, 2025, at 1:10 pm ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay will be archived for 90 days following the event.

About Codexis

Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.

For More Information

Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com

Media Contact
Lauren Musto
(650) 421-8205
media@codexis.com


FAQ

When is Codexis (CDXS) presenting at the TD Cowen Health Care Conference 2025?

Codexis will participate in a fireside chat on Tuesday, March 4, 2025, at 1:10 pm ET during the TD Cowen 45th Annual Health Care Conference in Boston.

How can investors watch Codexis's (CDXS) presentation at the TD Cowen conference?

Investors can watch the live webcast through Codexis's Investor Relations website at https://ir.codexis.com. A replay will be available for 90 days after the event.

How long will the replay of Codexis's (CDXS) TD Cowen conference presentation be available?

The replay of Codexis's presentation will be archived and available for 90 days following the event on their investor relations website.

Where is the 2025 TD Cowen Health Care Conference featuring Codexis (CDXS) being held?

The TD Cowen 45th Annual Health Care Conference is being held in Boston, Massachusetts from March 3-5, 2025.
Codexis Inc

NASDAQ:CDXS

CDXS Rankings

CDXS Latest News

CDXS Latest SEC Filings

CDXS Stock Data

159.87M
87.72M
2.28%
80.74%
5.54%
Biotechnology
Industrial Organic Chemicals
Link
United States
REDWOOD CITY